Tags : CRC

Biotech

Evotec Signs a Research Agreement with Indivumed to Develop Precision

Shots: Indivumed to receive upfront from Evotec, for accessing Indivumed’s database “IndivuType” and both companies will jointly invest in data analysis, target identification, validation, and drug discovery. Evotec will be responsible for upcoming partnering for the program/platform The focus of the agreement is to develop precision therapies for CRC patients with the combination of Evotec’s […]Read More